Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: 16-Week Efficacy and Safety Results From the Phase 3, Randomized, Double-Blind, Placebo-Controlled SPROUT Study

被引：0
|
作者：
Fiorillo, Loretta [1 ]
Becker, Emily [2 ]
de Lucas, Raul [3 ]
Belloni-Fortina, Anna [4 ]
Maes, Peter [5 ]
Oberoi, Rajneet K. [5 ]
Paris, Maria [5 ]
Zhang, Wendy [5 ]
Zhang, Zuoshun [5 ]
Arkin, Lisa
机构：
[1] Univ Alberta, Stollery Childrens Hosp, Edmonton, AB, Canada
[2] Driscoll Childrens Hosp, Corpus Christi, TX USA
[3] Hosp Univ La Paz PPDS, Madrid, Spain
[4] Azienda Osped Univ Padova, Padua, Italy
[5] Amgen Inc, Thousand Oaks, CA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
42163
引用
下载
收藏
页码：AB122 / AB122
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 16-week results from SPROUT, a randomized controlled trial
    Fiorillo, Loretta
    Becker, Emily
    de Lucas, Raul
    Belloni-Fortina, Anna
    Armesto, Susana
    Elewski, Boni
    Maes, Peter
    Oberoi, Rajneet K.
    Paris, Maria
    Zhang, Wendy
    Zhang, Zuoshun
    Arkin, Lisa
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (06) : 1232 - 1239
  • [2] Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: Results of a phase 3b, multicenter, randomized, placebo-controlled, double-blind study
    Van Voorhees, Abby S.
    Gold, Linda Stein
    Lebwohl, Mark
    Strober, Bruce
    Lynde, Charles
    Tyring, Stephen
    Cauthen, Ashley
    Sofen, Howard
    Zhang, Zuoshun
    Paris, Maria
    Wang, Yao
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) : 96 - 103
  • [3] Efficacy and safety of adalimumab in Chinese patients with moderate to severe plaque psoriasis: Results from a phase 3, randomized, placebo-controlled, double-blind Study
    Zhang, Jianzhong
    Gu, Jun
    Zheng, Jie
    Zheng, Min
    Wang, Gang
    Gu, Yihua
    Okun, Martin
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB232 - AB232
  • [4] Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial
    Gold, Linda Stein
    Papp, Kim
    Pariser, David
    Green, Lawrence
    Bhatia, Neal
    Sofen, Howard
    Albrecht, Lorne
    Gooderham, Melinda
    Chen, Mindy
    Paris, Maria
    Wang, Yao
    Duffin, Kristina Callis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (01) : 77 - 85
  • [5] Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind study
    Cai, L.
    Gu, J.
    Zheng, J.
    Zheng, M.
    Wang, G.
    Xi, L. -Y.
    Hao, F.
    Liu, X. -M.
    Sun, Q. -N.
    Wang, Y.
    Lai, W.
    Fang, H.
    Tu, Y. -T.
    Sun, Q.
    Chen, J.
    Gao, X. -H.
    Gu, Y.
    Teixeira, H. D.
    Zhang, J. -Z.
    Okun, M. M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (01) : 89 - 95
  • [6] Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial
    Merola, Joseph F.
    Parish, Lawrence Charles
    Guenther, Lyn
    Lynde, Charles
    Lacour, Jean -Philippe
    Staubach, Petra
    Cheng, Sue
    Paris, Maria
    Picard, Hernan
    Deignan, Cynthia
    Jardon, Shauna
    Chen, Mindy
    Papp, Kim A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (03) : 485 - 493
  • [7] The efficacy and safety of tofacitinib in Asian patients with moderate to severe chronic plaque psoriasis: A Phase 3, randomized, double-blind, placebo-controlled study
    Zhang, JianZhong
    Tsai, Tsen-Fang
    Lee, Min-Geol
    Zheng, Min
    Wang, Gang
    Jin, HongZhong
    Gu, Jun
    Li, RuoYu
    Liu, QuanZhong
    Chen, Jin
    Tu, CaiXia
    Qi, ChunMei
    Zhu, Hua
    Ports, William C.
    Crook, Tim
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2017, 88 (01) : 36 - 45
  • [8] Efficacy and Safety of Brodalumab In Patients With Moderate To Severe Plaque Psoriasis: Results of AMAGINE-1, a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
    Papp, K.
    Reich, K.
    Blauvelt, A.
    Baran, W.
    Bolduc, C.
    Toth, D.
    Gottlieb, A. B.
    Thaci, D.
    Li, J.
    Nirula, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S8 - S8
  • [9] Efficacy and safety of brodalumab in patients with moderate to severe plaque psoriasis: Results of AMAGINE-1, a phase 3, randomized, double-Blind, placebo-controlled study
    Papp, Kim
    Reich, Kristian
    Leonardi, Craig
    Paul, Carle
    Blauvelt, Andrew
    Baran, Wojciech
    Bolduc, Chantal
    Toth, Darryl
    Langley, Richard G.
    Cather, Jennifer
    Gottlieb, Alice
    Thaci, Diamant
    Milmont, Cassandra E.
    Lim, Joanne
    Klekotka, Paul
    Kricorian, Greg
    Nirula, Ajay
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S8 - S8
  • [10] Efficacy and safety of brodalumab in patients with moderate to severe plaque psoriasis: Results of AMAGINE-1, a phase 3, randomized, double-blind, placebo-controlled study through week 12
    Papp, Kim
    Reich, Kristian
    Leonardi, Craig
    Paul, Carle
    Blauvelt, Andrew
    Baran, Wojciech
    Bolduc, Chantal
    Toth, Darryl
    Langley, Richard
    Cather, Jennifer
    Gottlieb, Alice
    Thaci, Diamant
    Milmont, Cassandra
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB233 - AB233
12345